Open AccessIndirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
Author(s) -
Schneeweis Christian,
Hassan Zonera,
Ascherl Katja,
Wirth Matthias,
Koutsouli Stella,
Orben Felix,
Krauß Lukas,
Schneider Carolin,
Öllinger Rupert,
Krämer Oliver H.,
Rad Roland,
Reichert Maximilian,
Robles Maria S.,
Saur Dieter,
Schneider Günter
Publication year - 2022
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1002/cac2.12280
Subject(s) - pi3k/akt/mtor pathway , cancer research , protein kinase b , oncogene , kras , biology , pancreatic cancer , cancer , discovery and development of mtor inhibitors , kinase , medicine , bioinformatics , gene , cell cycle , signal transduction , genetics , mutation